Troikaa Pharmaceuticals

  1. Home / Division / Medical Devices
  2. Troikaa Pharmaceuticals

Dynapar AQ (Aquatech Technology)

Dynapar AQ is a novel Diclofenac injection manufactured by the Aquatech Process, which provides the full dose of 75 mg Diclofenac in just 1 ml.
The Aquatech process provides the optimal concentration of Diclofenac in an aqueous solvent system, thereby, providing the full therapeutic dose in a smaller volume.
The reduced volume of injection and the low viscosity of the solution in Dynapar AQ ensures that the injection is virtually painless.
The multiple advantages of Dynapar AQ have been demonstrated through a number of clinical trials. No wonder, Dynapar AQ has won several awards and accolades.

Dynapar QPS (Quick Penetrating Solution Technology)

Dynapar QPS is the world’s first Transdermal preparation of Diclofenac, which provides excellent pain relief after topical application, by enhancing the penetration of Diclofenac through the skin. Dynapar QPS is backed by proof of concept pharmacokinetic studies as well as clinical trials. Since Dynapar QPS provides prompt pain relief upon being administered to any inflamed area (knee, back, elbow, neck, ankle, etc.), it minimizes or eliminates the patient’s requirement of oral pain killers. Dynapar QPS, therefore, brings a paradigm shift in the management of musculoskeletal pain.

Phlebotroy QPS (Quick Penetrating Solution Technology)

Phlebotroy QPS is used in prevention and treatment of thrombophlebitis.
Phlebotroy QPS is a new generation topical solution which ensures higher penetration of Heparin as compared to conventional ointment/gel. It is backed by multicentric clinical trials and is manufactured using the globally patented QPS technology. Each ml of Phlebotroy QPS contains 1000 IU/ml of Heparin Sodium.
Phlebotroy QPS offers significant reduction in the length of venous lesion, better improvement in grades of Phlebitis and complete resolution of Phlebitis in 90% of the patients as compared to heparin gel. Prophylactic application of Phlebotroy QPS is effective in preventing development of superficial thrombophlebitis.